0000882291 1 2026-06-17 2026-06-17 0000882291 2 2026-06-17 2026-06-17 0000882291 3 2026-06-17 2026-06-17 0000882291 4 2026-06-17 2026-06-17 0000882291 2026-06-17 2026-06-17 iso4217:USD pure shares S-1 EX-FILING FEES 0000882291 N/A N/A S-1 Aethlon Medical Inc. false Equity Common Stock, $0.001 par value per share true 6000000 2.00 12000000.00 0.0001381 1657.20 false Equity Common Stock Underlying Common Stock Warrants true 6000000 2.00 12000000.00 0.0001381 1657.20 false Equity Common Stock Underlying Pre-Funded Warrants true 6000000 0.0010 6000.00 0.0001381 0.83 false Equity Common Stock Underlying Placement Agent Warrants true 240000 2.00 480000.00 0.0001381 66.29 24486000.00 3381.52 0.00 0.00 3381.52 Represents shares of common stock issuable upon exercise of the Common Stock Warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Common Stock Warrants is $2.00, which is the exercise price for the Common Stock Warrants. Represents shares of common stock issuable upon exercise of the Pre-Funded warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Pre-Funded Warrants is $0.001, which is the exercise price for the Pre-Funded Warrants. Represents shares of common stock issuable upon exercise of the Placement Agent Warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Placement Agent Warrants is $2.00, which is the exercise price for the Placement Agent Warrants.